CASI Pharmaceuticals, Inc.·4

Mar 4, 4:51 PM ET

CASI Pharmaceuticals, Inc. 4

4 · CASI Pharmaceuticals, Inc. · Filed Mar 4, 2016

Insider Transaction Report

Form 4
Period: 2016-03-02
Wu Alex
Director
Transactions
  • Award

    Options (Right to Buy)

    2016-03-02+35,00035,000 total
    Exercise: $0.88Exp: 2026-03-02Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]Stock option award will vest ratably quarterly to the end of one year.

Documents

1 file
  • 4
    v433408_4.xmlPrimary

    OWNERSHIP DOCUMENT